Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Perspectives

  3. Lung cancer screenings on the verge of starting?
Oncology

Lung cancer screenings on the verge of starting?

Read the full Q&A with Marie-Pierre Revel, Professor of Radiology and Head of the Radiology Department at Cochin Hospital, Université de Paris, France on Politico.

2min
Published on February 4, 2022

Five seconds that can make the difference to survival. Because that's all it takes to perform a low-dose CT scan, one of the most efficient ways to detect lung cancer. Nevertheless, regular screenings are still not a common occurrence today. 

A total of 5,000 deaths, worldwide, per day.[1] This makes lung cancer one of the most dangerous cancers. Early detection is essential to improve survival, but it is also the Achilles' heel of medical care: Lack of or diffuse symptoms in the early stages make it difficult for patients to seek help in time and thus the disease is often diagnosed (too) late. Systematic early detection, for example through screening of patients at risk, could close an important gap here.

If you look at other screening programs — those screenings were heavily pushed and promoted by the patient organizations. It’s different for lung cancer, and the reason is very sad: patient organizations mainly comprise survivors; in lung cancer, we don't have so many survivors. But more and more frequently, medical and scientific organizations have started to promote screening for the benefit of their patients.

Sebastian Schmidt, MD, Head of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers
Learn more about countries that have established lung cancer screening programs, how they work, and why women in particular could benefit from this type of cancer screening for other diseases in the Q&A with Marie-Pierre Revel, Professor of Radiology and Head of the Radiology Department at Cochin Hospital, Université de Paris, France, and Sebastian Schmidt, MD, Head of Strategy and Medical Affairs at Siemens Healthineers. Get the full interview on Politico here

Technologies that are set to revolutionize cancer care

"Whilst it sometimes feels that the 'hidden pandemic' called cancer is something we are expected to get used to, we should not accept it", says Bernd Montag, CEO Siemens Healthineers. Read more 
Bernd Montag

Read more

A sharper focus in radiation therapy planning
siemens-healthineers_press_press-release_varian_ASTRO

Varian highlights combination with Siemens Healthineers at American Society for Radiation Oncology (ASTRO) Annual Meeting
  1. [1] Statista. (2021, 3. Februar). Zahl der Krebstodesfälle nach Krebsart weltweit 2020. Abgerufen am 24. Januar 2022, von https://de.statista.com/statistik/daten/studie/286584/umfrage/zahl-der-krebstodesfaelle-nach-krebsart-weltweit/